Product
HydroVax-002
1 clinical trial
1 indication
Indication
Yellow feverClinical trial
A Double Blind, Randomized, Placebo-Controlled, Phase 1 Dose Escalation Trial to Evaluate the Safety and Immunogenicity of an Inactivated Yellow Fever Virus Vaccine, HydroVax-002 YFV, in Healthy AdultsStatus: Completed, Estimated PCD: 2022-10-19